Episode 7

Diagnostics That Change Patient Care | Dr. Russell Grant

What happens when a scientist moves from pharmaceutical development into the world of clinical diagnostics?

Dr. Russell Grant joins BioTalk Unzipped to discuss a career that has taken him from the United Kingdom to the United States, from large pharmaceutical organizations into diagnostics, and across the evolving worlds of mass spectrometry and laboratory medicine.

Russ explains important differences between bioanalysis supporting clinical trials and laboratory testing used directly in patient care. He also shares his experience working through the extraordinary demands created by COVID-19 and why seemingly small improvements in laboratory efficiency can have meaningful consequences when multiplied across thousands of patients.

The conversation also examines a remarkable gene therapy story involving the restoration of hearing in a child with genetic hearing loss.

Beyond the technology, Russ discusses why diagnostics became such an important part of his career, the role scientific integrity plays in trustworthy research, and what concerns him about problems within scientific literature.

It is a conversation about science, healthcare, professional reinvention, and the responsibility researchers have to get the science right.